BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22227861)

  • 21. MED15, transforming growth factor beta 1 (TGF-β1), FcγRIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma.
    Elahi M; Rakhshan V
    Sci Rep; 2020 May; 10(1):8475. PubMed ID: 32439976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
    Wang K; Jin J; Ma T; Zhai H
    J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma.
    Ota K; Fujimori H; Ueda M; Jono H; Shinriki S; Ota T; Sueyoshi T; Taura M; Taguma A; Kai H; Shinohara M; Ando Y
    Int J Oncol; 2010 Oct; 37(4):797-804. PubMed ID: 20811700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
    Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
    BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. circIGHG-Induced Epithelial-to-Mesenchymal Transition Promotes Oral Squamous Cell Carcinoma Progression via miR-142-5p/IGF2BP3 Signaling.
    Liu J; Jiang X; Zou A; Mai Z; Huang Z; Sun L; Zhao J
    Cancer Res; 2021 Jan; 81(2):344-355. PubMed ID: 33203701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA‑495 targets Notch1 to prohibit cell proliferation and invasion in oral squamous cell carcinoma.
    Lv L; Wang Q; Yang Y; Ji H
    Mol Med Rep; 2019 Jan; 19(1):693-702. PubMed ID: 30387817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.
    Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
    Wen J; Xu H; Liu R; Chen Q; Dai Y; Xu Y
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):24-31. PubMed ID: 32538743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma.
    Duan Q; Xu M; Wu M; Zhang X; Gan M; Jiang H
    Cancer Med; 2020 May; 9(9):3115-3129. PubMed ID: 32130788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter DNA Methylation and mRNA Expression Level of p16 Gene in Oral Squamous Cell Carcinoma: Correlation with Clinicopathological Characteristics.
    Allameh A; Moazeni-Roodi A; Harirchi I; Ravanshad M; Motiee-Langroudi M; Garajei A; Hamidavi A; Mesbah-Namin SA
    Pathol Oncol Res; 2019 Oct; 25(4):1535-1543. PubMed ID: 30511108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Underexpression of α-1-microglobulin/bikunin precursor predicts a poor prognosis in oral squamous cell carcinoma.
    Sekikawa S; Onda T; Miura N; Nomura T; Takano N; Shibahara T; Honda K
    Int J Oncol; 2018 Dec; 53(6):2605-2614. PubMed ID: 30272341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
    Bu J; Bu X; Liu B; Chen F; Chen P
    Med Sci Monit; 2015 Aug; 21():2275-81. PubMed ID: 26242444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma.
    Mohanta S; Sekhar Khora S; Suresh A
    Arch Oral Biol; 2019 Mar; 99():92-106. PubMed ID: 30641296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
    Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
    J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NIPA-like domain containing 1 is a novel tumor-promoting factor in oral squamous cell carcinoma.
    Sasahira T; Nishiguchi Y; Kurihara-Shimomura M; Nakashima C; Kuniyasu H; Kirita T
    J Cancer Res Clin Oncol; 2018 May; 144(5):875-882. PubMed ID: 29464350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition.
    de Lima JM; Morand GB; Macedo CCS; Diesel L; Hier MP; Mlynarek A; Kowalski LP; Maschietto M; Alaoui-Jamali MA; da Silva SD
    Carcinogenesis; 2020 Jul; 41(6):769-777. PubMed ID: 32112078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence.
    Reis PP; Waldron L; Perez-Ordonez B; Pintilie M; Galloni NN; Xuan Y; Cervigne NK; Warner GC; Makitie AA; Simpson C; Goldstein D; Brown D; Gilbert R; Gullane P; Irish J; Jurisica I; Kamel-Reid S
    BMC Cancer; 2011 Oct; 11():437. PubMed ID: 21989116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.